CSBR
Champions Oncology Inc
4.90$
+1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 49.4% | 67.5% | 69.1% | 52.5% | 51.0% | 48.7% | 57.2% | 49.5% | 51.6% | 53.3% | 55.7% | 55.7% | 50.9% | 48.0% | 56.3% | 55.9% | 55.8% | 42.8% | 53.2% | 48.0% | 47.6% | 48.6% | 48.3% | 51.3% | 52.1% | 60.3% | 56.1% | 61.2% | 57.2% | 65.3% | 51.8% | 50.3% | 55.1% | 38.8% | 58.9% | 57.1% | 48.3% | 53.3% | 49.2% | 51.5% | 50.7% | |
| 50.6% | 32.5% | 30.9% | 47.5% | 49.0% | 51.3% | 42.8% | 50.5% | 48.4% | 46.7% | 44.3% | 44.3% | 49.1% | 52.0% | 43.7% | 44.1% | 44.2% | 57.2% | 46.8% | 52.0% | 52.4% | 51.4% | 51.7% | 48.7% | 47.9% | 39.7% | 43.9% | 38.8% | 42.8% | 34.7% | 48.2% | 49.7% | 44.9% | 61.2% | 41.1% | 42.9% | 51.7% | 46.7% | 50.8% | 48.5% | 49.3% | |
| 22.6% | 28.0% | 28.9% | 22.2% | 21.4% | 20.6% | 22.2% | 17.5% | 17.8% | 19.7% | 16.2% | 19.3% | 17.6% | 15.4% | 20.8% | 16.7% | 16.3% | 17.4% | 19.6% | 20.5% | 19.5% | 16.5% | 20.1% | 21.0% | 18.2% | 25.1% | 21.8% | 22.2% | 21.7% | 18.2% | 14.6% | 10.3% | 12.5% | 10.1% | 15.9% | 14.9% | 17.4% | 13.7% | 15.3% | 15.4% | 15.4% | |
| 22.9% | 23.5% | 42.2% | 24.0% | 18.3% | 19.8% | 18.4% | 16.9% | 15.4% | 19.0% | 17.7% | 21.2% | 14.9% | 17.3% | 28.5% | 14.5% | 14.5% | 17.0% | 17.3% | 19.1% | 16.8% | 16.9% | 21.4% | 17.4% | 17.7% | 20.1% | 21.0% | 23.4% | 22.5% | 23.0% | 19.7% | 18.0% | 14.0% | 14.1% | 20.4% | 18.4% | 19.8% | 18.0% | 19.0% | 17.5% | 18.6% | |
| 61.6% | 71.8% | 95.1% | 59.8% | 50.4% | 52.7% | 55.0% | 42.7% | 44.3% | 52.4% | 45.8% | 53.4% | 45.3% | 47.2% | 65.6% | 43.9% | 44.1% | 48.2% | 50.8% | 53.6% | 50.2% | 45.2% | 54.1% | 50.8% | 47.8% | 59.0% | 63.1% | 59.1% | 59.7% | 56.1% | 50.2% | 40.3% | 39.5% | 34.8% | 55.0% | 46.5% | 50.5% | 47.8% | 55.3% | 51.2% | 51.0% | |
| -11.1% | -39.3% | -64.2% | -12.3% | -1.3% | -1.3% | -12.2% | 7.7% | 4.1% | -5.8% | -1.5% | -9.1% | 3.8% | 4.8% | -21.9% | 0.3% | 0.1% | 9.1% | -4.1% | -1.6% | 2.2% | 6.3% | -2.4% | -2.1% | 0.0% | -19.2% | -19.3% | -20.3% | -16.9% | -21.4% | -1.9% | 9.5% | 5.4% | 26.4% | -13.9% | -3.6% | 1.2% | -1.1% | -4.6% | -2.7% | -1.7% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | 0.2% | 4.1% | 0.1% | 0.1% | 4.8% | 4.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -11.4% | -39.5% | -64.8% | -13.3% | -1.6% | -1.5% | -12.5% | 7.7% | 4.0% | -5.7% | -1.9% | -9.3% | 4.2% | 4.6% | -22.3% | 0.9% | 0.2% | 9.0% | -4.0% | -1.4% | 2.5% | 6.0% | -2.7% | -2.2% | 0.0% | -19.0% | -19.4% | -20.2% | -17.8% | -21.0% | -1.4% | 9.5% | 5.5% | 26.5% | -15.9% | -3.2% | 1.7% | -1.4% | -3.6% | -2.7% | -1.5% | |
| -0.1% | 0.1% | 0.3% | 0.1% | 0.2% | 0.0% | 0.3% | 0.2% | 0.0% | 0.0% | 1.3% | 0.2% | 0.1% | 0.1% | 1.1% | 0.1% | 0.1% | 0.1% | 0.3% | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% | 0.1% | 0.1% | 0.2% | 0.2% | 0.1% | 0.1% | -0.6% | 0.1% | 0.1% | 0.1% | -1.0% | 0.1% | 0.1% | 0.3% | 1.2% | 0.1% | 0.4% | |
| -11.3% | -39.5% | -65.2% | -13.4% | -1.8% | -1.5% | -12.8% | 7.7% | 4.0% | -5.7% | -3.3% | -9.5% | 4.0% | 4.5% | -23.4% | 0.8% | 0.0% | 8.9% | -4.3% | -1.5% | 2.4% | 6.0% | -2.7% | -2.3% | -0.1% | -19.1% | -19.6% | -20.4% | -17.9% | -21.1% | -0.8% | 9.3% | 5.4% | 26.4% | -14.9% | -3.3% | 2.0% | -1.7% | -5.3% | -2.8% | -1.9% | |
| -10.1% | -38.2% | -63.1% | -11.5% | 0.4% | 1.1% | -10.0% | 9.6% | 6.4% | -3.2% | 0.7% | -6.4% | 6.2% | 7.2% | -15.2% | 3.1% | 3.1% | 11.8% | -1.2% | 1.4% | 5.4% | 9.1% | 1.7% | 1.6% | 3.9% | -14.5% | -8.7% | -16.7% | -13.6% | -17.0% | 4.4% | 12.7% | 8.4% | 28.9% | -12.7% | -0.7% | 4.1% | 0.6% | -1.3% | -0.6% | 0.7% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.